| 6 April | 1PM - 4PM EST (New York) |
| 6PM - 9PM GMT (London) | |
| 7PM - 10PM CET (Paris) | |
| 7 April | 3AM - 6AM AEST (Sydney) |
Panelists: Jessica Lawrence DVM, DACVIM (Onc.), DACVR (Rad. Onc.), DECVDI (Rad. Onc.) - University of Minnesota, USA
Laura Marconato DVM, DECVIM-CA (Onc.) - University of Bologna, Italy
Bernard Seguin DVM, MS, DACVS - Central Victoria Veterinary Hospital, VCA Canada
Moderator: Nick Bacon MA, VetMB, CertVR, CertSAS, DECVS, DACVS, FRCVS - AURA Veterinary, UK
PANEL DISCUSSION DESCRIPTION
Osteosarcoma is the commonest malignant bone tumor in dogs, and the commonest cancer in Greyhounds. Other types of bone cancer are seen however in the limbs of both dogs and cats, as well as metastatic bone lesions from a variety of primary cancers elsewhere. This complex disease therefore forces the clinician to make a variety of decisions, including;
· What is the best way to get a biopsy, and do we always need a biopsy?
· What surgery (if any) is appropriate or possible?
· What chemotherapy drugs do I give, and how long for?
· When should we discuss radiation therapy, and what are the options?
· What is the best palliative approach for these patients if surgery is declined or not appropriate?
· Is there anything we can do if we discover the bone tumor has metastasized?
· Do we treat all primary appendicular bone tumors the same way?
· Which tumors metastasize to bone and how do I manage the case?
The multidisciplinary panel assembled to carefully navigate their way through this complicated landscape are all world-renowned specialist clinicians, with a track record of clinical oncologic research to help support their decision-making. There will undoubtedly be wide-ranging discussion on the issues raised above as well as innovations in the pipeline to help with diagnosis, treatment, and prognostication of appendicular bone tumors.
* Participants are encouraged to send in questions to info@vetpd.com prior to the panel discussion. There will also be the opportunity to raise questions during the discussion.
Panel Discussion Registration Process: Once you have registered and upon payment, you will receive an invitation to the live panel discussion in due course. The panel discussion will be recorded and after the session has taken place, you will receive the link to access the on-demand recording for a period of 8 weeks. The course fee includes a certificate of attendance, that will be issued once the webinar series / webinar has ended and your attendance has been confirmed.
United Kingdom
European & American Specialist in Small Animal Vererinary Surgery
More Info
Professor Nick Bacon completed a residency in Small Animal Surgery at Cambridge University, a Fellowship in Surgical Oncology at the Animal Cancer Center at Colorado State University and spent 9 years as Surgical Oncology Faculty at the University of Florida, becoming Head of Oncology. In 2014 he moved back to the UK and was appointed Professor of Surgical Oncology at the University of Surrey School of Veterinary Medicine and co-founded Fitzpatrick Referrals Oncology and Soft Tissue, now AURA Veterinary, in Guildford, Surrey. AURA Veterinary has the largest and most experienced team of medical, surgical and interventional oncologists in the country and treats patients from across the UK and mainland Europe.
Nick is a Diplomate of the European and American Colleges of Veterinary Surgeons, a Past-President of the Veterinary Society of Surgical Oncology, and an ACVS Founding Fellow of Surgical Oncology. He has been awarded specialist status in Surgical Oncology by the Royal College of Veterinary Surgeons (RCVS) and was appointed a Fellow of the RCVS due to his Contribution to Clinical Practice. Nick is a founder member of the Oncology Working Group of the World Small Animal Veterinary Association (WSAVA), and is on the Specialist Advisory Board for the veterinary homeless charity StreetVet.
Full details
Canada
American Specialist in Veterinary Surgery
More Info
Dr. Séguin obtained his DVM from the University of Montréal. He performed a small animal internship at the University of Illinois. He was in small animal general private practice before completing a Master’s of Science and Small Animal Surgery Residency at Washington State University. He then went on to fulfill his Fellowship in Surgical Oncology at Colorado State University. He was on Faculty at the University of California, Davis, and Oregon State University, and was a full Professor of Surgical Oncology at the Flint Animal Cancer Center, Colorado State University. He has lectured nationally and internationally and has authored numerous scientific articles and book chapters. Dr. Séguin is the co-editor of the textbook Veterinary Surgical Oncology, now in its second edition. He is a specialist in veterinary surgery (Diplomate of the American College of Veterinary Surgeons) and an ACVS Founding Fellow of Surgical Oncology and an ACVS Founding Fellow of Oral and Maxillofacial Surgery. Dr. Séguin has joined the Central Victoria Veterinary Hospital as a Veterinary Specialist in Surgical Oncology and Surgery.
Full details
United States
American Specialist in Veterinary Internal Medicine (Onc.), American Specialist in Veterinary Radiology (Rad. Onc.) and European Specialist in Veterinary Diagnostic Imaging (Rad. Onc.)
More Info
Jessica Lawrence joined the University of Minnesota College of Veterinary Medicine in 2016 as an Associate Professor of Radiation Oncology. She earned her DVM from the Ontario Veterinary College and completed advanced training in radiation and medical oncology at the University of Wisconsin-Madison. Prior to joining the MCVM, Dr. Lawrence spent 3 years as an Assistant Professor of Medical Oncology at the University of Georgia before spending 3.5 years as the Head of Oncology at the Royal (Dick) School of Veterinary Studies at the University of Edinburgh. Dr. Lawrence has a strong interest in comparative oncology, and she aims to provide exceptional quality of life for pets with cancer and their owners. Dr. Lawrence is particularly interested in tumor and normal tissue radiation sensitivity and developing methods to improve tumor control with radiation therapy while minimizing side effects.
Dr. Lawrence is a clinician researcher fully engaged in the “One Health” directive as she strives to improve our understanding of the pathobiology, diagnosis, treatment and prevention of human and animal cancer and treatment-related toxicities. In particular, she is keen to improve radiation killing of cancer cells while limiting radiation-induced injury to normal tissue that may result in treatment-related complications such as organ fibrosis and bystander injury. As cancer survivors (pet or human) enjoy improved outcomes after radiation therapy for many tumor types, it is important that cancer researchers investigate treatment methods to maintain or improve quality of life after treatment. By furthering our understanding of the signals that occur after radiation in normal and cancer cells, Dr. Lawrence and her collaborators hope to develop strategies that mitigate radiation-induced injury to normal tissue.
Full details
Italy
European Specialist in Veterinary Internal Medicine-CA (Onc)
More Info
Dr Marconato obtained her degree in Veterinary Medicine (School of Veterinary Medicine, Milan) in 1999 and is a Diplomate of ECVIM-CA (Oncology) since 2008. In 2000-2003 she trained in medical oncology at the Veterinary Oncology Service and Research Center (West Chester) and at the Veterinary Oncology Services’ Radiation Center, Chalfont, PA, USA. In 2009-2011 she worked as co-head of medical oncology at the Animal Oncology and Imaging Center, Hünenberg (Switzerland), before returning to Italy as head of medical oncology at the Centro Oncologico Veterinario from 2011to 2019.
She is currently the Head of Medical Oncology and Associate Professor at the University of Bologna (Italy). She has been speaker at numerous scientific meetings, nationally and internationally, and author of >130 peer-reviewed papers. In 2011-2015 she became President of the Italian Veterinary Oncology Society (SIONCOV). Since 2014 she is the Chair of Workgroup 2 (Therapy) of the European Network of Canine Lymphoma. She is also member of VCS, ESVIM, SIONCOV.
Her research interest focuses on the dog as a spontaneous model of cancer. She is involved in many projects related to translational oncology, including active immunotherapy for the treatment of canine lymphoma, osteosarcoma, hemangiosarcoma and melanoma, in collaboration with national and international research centres.
Full details